# Developmental Funds

> **NIH NIH P30** · UNIVERSITY OF CALIFORNIA-IRVINE · 2022 · $209,681

## Abstract

DEVELOPMENTAL FUNDS
PROJECT SUMMARY/ABSTRACT
The Chao Family Comprehensive Cancer Center (CFCCC) utilizes Developmental Funds to support critical
priorities, aligned with strategic planning, in order to grow and enhance key scientific areas. Prior funds provided
support for staff investigators, faculty recruitment and pilot project funding. In the future funding period,
investments will continue to be focused in these three areas:
Faculty Recruitment: CFCCC has been extensively focused on the recruitment of cancer-focused faculty
recruitments during the current funding period and this remains a priority as outlined in the 2020-2025 CFCCC
Strategic Plan. CFCCC requests Cancer Center Support Grant (CCSG) funds for partial support of strategic
faculty recruitments.
Pilot Project Funding: The investment in research proposals to pursue innovative ideas and stimulate high
priority research areas (e.g., population science, translational research, research on underrepresented
populations, and early phase clinical trials) are critical to ensure a high likelihood of future extramural grant
awards. CCSG Developmental Funds will supplement additional funds provided through the Anti-Cancer
Challenge (a peer-to-peer fundraising initiative established by Center Director Richard Van Etten, MD, PhD),
philanthropic, and other institutional funds.
Research Staff Investigators: CFCCC staff investigators are supported through CCSG Developmental Funds
to foster the advancement of key strategic objectives of the Center. Staff Investigators enable the advancement
of priority strategic objectives of the CFCCC. The funded researchers are CFCCC members who are important
contributors to the scientific, translational, and clinical research activities of the Center and who serve in a
significant role in helping the Center achieve scientific objectives above and beyond their own research. During
the future funding period, support will be provided for Farshid Dayyani, MD, PhD and Edward Uchio, MD who
are disease leaders of and significant contributors to clinical research activity, enrolling a large number of patients
in trials and developing and writing investigator-initiated trials with specific regard to CFCCC's Catchment Area.

## Key facts

- **NIH application ID:** 10334387
- **Project number:** 2P30CA062203-24
- **Recipient organization:** UNIVERSITY OF CALIFORNIA-IRVINE
- **Principal Investigator:** RICHARD A. VAN ETTEN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $209,681
- **Award type:** 2
- **Project period:** 1997-09-11 → 2027-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10334387

## Citation

> US National Institutes of Health, RePORTER application 10334387, Developmental Funds (2P30CA062203-24). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10334387. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*